Opin vísindi

Fletta eftir höfundi "van Vollenhoven, Ronald"

Fletta eftir höfundi "van Vollenhoven, Ronald"

Röðun: Raða: Niðurstöður:

  • Icon
    Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. 
    Almeida-Brasil, Celline C; Hanly, John G; Urowitz, Murray; Clarke, Ann Elaine; Ruiz-Irastorza, Guillermo; Gordon, Caroline; Ramsey-Goldman, Rosalind; Petri, Michelle; Ginzler, Ellen M; Wallace, D J; Bae, Sang-Cheol; Romero-Diaz, Juanita; Dooley, Mary Anne; Peschken, Christine; Isenberg, David; Rahman, Anisur; Manzi, Susan; Jacobsen, Søren; Lim, Sam; van Vollenhoven, Ronald F; Nived, Ola; Jönsen, Andreas; Kamen, Diane L; Aranow, Cynthia; Sanchez-Guerrero, Jorge; Gladman, Dafna D; Fortin, Paul R; Alarcón, Graciela S; Merrill, Joan T; Kalunian, Kenneth; Ramos-Casals, Manuel; Steinsson, Kristján; Zoma, Asad; Askanase, Anca; Khamashta, Munther A; Bruce, Ian N; Inanc, Murat; Abrahamowicz, Michal; Bernatsky, Sasha (2022-02-14)
    Objectives: To evaluate systemic lupus erythematosus (SLE) flares following hydroxychloroquine (HCQ) reduction or discontinuation versus HCQ maintenance. Methods: We analysed prospective data from the Systemic Lupus International Collaborating Clinics ...
  • Icon
    Methotrexate safety and efficacy in combination therapies in patients with early rheumatoid arthritis : a post-hoc analysis of a randomized controlled trial (NORD-STAR) 
    Lend, Kristina; Koopman, Frieda A; Lampa, Jon; Jansen, Gerrit; L, Merete Hetland; Uhlig, Till; Nordström, Dan; Nurmohamed, Michael; Guðbjörnsson, Björn; Rudin, Anna; Østergaard, Mikkel; Heiberg, Marte S; Sokka-Isler, Tuulikki; Hørslev-Petersen, Kim; Haavardsholm, Espen A; Gröndal, Gerður María; Twisk, Jos W R; van Vollenhoven, Ronald (2023-10-17)
    OBJECTIVE: To investigate methotrexate safety and influence of dose on efficacy outcomes in combination with three different biological treatments and with active conventional treatment (ACT) in early rheumatoid arthritis (RA). METHODS: This post-hoc ...
  • Icon
    Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine 
    Almeida-Brasil, Celline C; Hanly, John G; Urowitz, Murray; Clarke, Ann Elaine; Ruiz-Irastorza, Guillermo; Gordon, Caroline; Ramsey-Goldman, Rosalind; Petri, Michelle; Ginzler, Ellen M; Wallace, Daniel J; Bae, Sang-Cheol; Romero-Diaz, Juanita; Dooley, Mary Anne; Peschken, Christine; Isenberg, David; Rahman, Anisur; Manzi, Susan; Jacobsen, Søren; Sam Lim, Sung; Van vollenhoven, Ronald F.; Nived, Ola; Jönsen, Andreas; Kamen, Diane L; Aranow, Cynthia; Sánchez-Guerrero, Jorge; Gladman, Dafna D.; Fortin, Paul R; Alarcon, Graciela S.; Merrill, Joan T; Kalunian, Kenneth; Ramos-Casals, Manuel; Steinsson, Kristján; Zoma, A A; Askanase, Anca D; Khamashta, Munther; Bruce, Ian N.; Inanc, Murat; Lukusa, Luck; Bernatsky, Sasha (2022-11-01)
    Objective To evaluate hydroxychloroquine (HCQ)-related retinal toxicity in the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Methods Data were collected at annual study visits between 1999 and 2019. We followed patients ...
  • Icon
    Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis 
    Liu, Jianyang; Idborg, Helena; Korotkova, Marina; Lend, Kristina; van Vollenhoven, Ronald; Lampa, Jon; Rudin, Anna; Nordström, Dan; Guðbjörnsson, Björn; Gröndal, Gerður María; Uhlig, Till; Hørslev-Petersen, Kim; Lund Hetland, Merete; Østergaard, Mikkel; Nurmohamed, Michael; Jakobsson, Per-Johan (2024-03-05)
    BACKGROUND: Disease-modifying antirheumatic drugs (DMARDs) are widely used for treating rheumatoid arthritis (RA). However, there are no established biomarkers to predict a patient's response to these therapies. Prostanoids, encompassing prostaglandins, ...